Baillie Gifford - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 225 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$37,213,621
-61.9%
3,971,571
-0.3%
0.03%
-59.0%
Q2 2023$97,713,906
+5.3%
3,983,445
-0.1%
0.08%
-1.2%
Q1 2023$92,754,825
-8.0%
3,986,026
+0.0%
0.08%
-20.0%
Q4 2022$100,850,251
+31.5%
3,984,601
+0.1%
0.10%
+32.9%
Q3 2022$76,709,000
-23.4%
3,978,657
+1.2%
0.08%
-23.3%
Q2 2022$100,119,000
-1.4%
3,930,852
-0.4%
0.10%
+45.1%
Q1 2022$101,521,000
-38.1%
3,947,160
+0.8%
0.07%
-21.1%
Q4 2021$163,942,000
-3.4%
3,915,501
+0.4%
0.09%
+1.1%
Q3 2021$169,715,000
-6.8%
3,899,692
+1.3%
0.09%0.0%
Q2 2021$182,005,000
-7.0%
3,849,509
+0.8%
0.09%
-18.3%
Q1 2021$195,705,000
+95.1%
3,817,148
+1.9%
0.11%
+94.6%
Q4 2020$100,290,000
-21.4%
3,744,948
+0.8%
0.06%
-36.4%
Q3 2020$127,567,000
-10.1%
3,715,888
+7.3%
0.09%
-18.5%
Q2 2020$141,887,000
+3087.8%
3,463,202
+2566.7%
0.11%
+2060.0%
Q1 2020$4,451,000
-29.2%
129,869
-74.0%
0.01%
-16.7%
Q4 2019$6,287,000500,0000.01%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q4 2022
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$39,461,88430.41%
SB INVESTMENT ADVISERS (UK) LTD 20,259,535$512,768,8314.28%
Zebra Capital Management LLC 37,449$9483.32%
CLARK ESTATES INC/NY 180,000$4,555,8000.95%
Temasek Holdings (Private) Ltd 5,710,510$144,533,0080.84%
SECTOR GAMMA AS 89,808$2,273,0400.52%
Avidity Partners Management LP 850,000$21,513,5000.47%
DCF Advisers, LLC 24,000$607,4400.41%
SummerHaven Investment Management, LLC 25,343$641,4310.38%
Capital Impact Advisors, LLC 13,196$333,9910.33%
View complete list of VIR BIOTECHNOLOGY INC shareholders